Each month, you will receive our free newsletter offering tips to help you and/or your loved one manage the cancer journey.
Read the latest issue
View a sample newsletter
Visit the newsletter archive
O-VAX: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse
Phase 1/2, open-label, randomized study of safety, efficacy, and pharmacokinetics of letrozole plus PD 0332991 (oral CDK 4/6 inhibitor) and letrozole single agent for the first-line treatment of ER positive, HER2 negative advanced breast cancer in postmenopausal women
A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer
A Phase I/II Study of the Safety and Biological Activity of Intraperitoneal EGEN-001 (IL-12 plasmid formulated with PEG-PEI- Cholesterol lipopolymer) Administered alone and in Combination with Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients who had Previously Received Cytoreductive Surgery plus HIPEC Therapy.
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury
A RANDOMIZED PHASE II STUDY OF IMETELSTAT (GRN163L) IN COMBINATION WITH PACLITAXEL (WITH OR WITHOUT BEVACIZUMAB) IN PATIENTS WITH LOCALLY RECURRENT OR METASTATIC BREAST CANCER
A Randomized Controlled Study of YONDELIS(R)(Trabectedin) or Dacarbazine for the treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated With an Anthracycline and Ifosfamide
Protocol Numbe CMT 01-10: Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy.
Protocol ET743-SAR-3002 Phase 3b: A Multicenter, Open-Label Single Arm Study of Yondelis(R)(Trabectedin)for Subjects with Locally Advanced or Metastatic Soft Tissue Sarcoma Excluding Leiomyosarcoma and Liposarcoma Who Have Relapse or Are Refractory to Standard of Care
Evaluation of Hyperthermia and Radiotherapy for the Treatment of Patients with Locally Advanced Tumors of the Pelvis
Chat Now.We're here 24/7.
